Isu Abxis ranked among the top searched stocks for 3 days in the past month.


As of 10:33 AM on the 15th, Isu Abxis is trading at 14,150 KRW, up 29.82% from the previous day. This represents a 102.43% increase compared to January 18. Isu Abxis, an affiliate of the Isu Group, is known as a company that develops antibiotic treatments and provides medical services.

Today, foreigners have a net purchase of 360,740 shares of Isu Abxis, while institutions have a net sale of 200,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 146,104 shares, while foreigners and institutions have net bought 114,525 shares and 72,480 shares, respectively.


On February 10, Isu Abxis was a market issue with the headline "Strong performance due to news of contract manufacturing of Russian COVID-19 vaccine."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing